X. Pan, D. Zheng, D. Zheng
Aug 1, 2019
Citations
3
Influential Citations
35
Citations
Quality indicators
Journal
European Journal of Neurology
Abstract
Tirofiban is used off‐label in clinical practice for acute ischaemic stroke (AIS). However, it is unknown whether tirofiban increases the bleeding risk or improves the outcome of endovascular treatment (EVT) in AIS. This study evaluated the efficacy and safety of tirofiban in combination with EVT for AIS.